This is a non-core endpoint: only basic statistics are computed.
Use of apomorphine
PDMED_APOMORPHINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
19 |
4. Check minimum number of events
Min. number of events
3
|
19 |
5. Include endpointsNone |
19 |
6. Filter based on genotype QC (FinnGen only) |
18 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Use of apomorphine based on the number of shared cases.
Similar with more cases:
- Use of levodopa decarboxylase inhibitor
- Parkinson's disease, strict definition
- Parkinson's disease, strict definition
- Parkinson's disease
- Parkinson's disease
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 18 | 10 | 8 |
Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.00 |
Median age at first event (years) | 64.75 | 64.23 | 65.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_APOMORPHINE – Use of apomorphine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).